论文部分内容阅读
脑动脉硬化症是老年人多发病之一,临床上常为对症治疗,效果多不明显。1985年,我们用广州光华制药厂生产的脑络通治疗脑动脉硬化症32例,效果较好,现将治疗结果报告于下。一、病例选择:本组32例,男27例,女5例;年龄55～65岁;病史5～20年。病例选择标准5条: 1.年龄在50岁以上。 2.有高级神经活动不稳定症状及/或脑弥漫性损害症状,如头痛、眩晕、乏力、失眠、嗜睡、记忆力减退、言语不清、手指震颤、走路不稳、性格改变、易激动等。 3.有全身动脉硬化的旁证,如眼底动脉硬化Ⅱ级
Cerebral arteriosclerosis is one of the most frequently-occurring diseases in the elderly, often symptomatic treatment clinically, the effect is not obvious. In 1985, we use brain Guanliao produced by Guanghua Pharmaceutical Factory in Guangzhou to treat 32 cases of cerebral arteriosclerosis, and the effect is better. The results of the treatment are reported below. First, the case selection: The group of 32 patients, 27 males and 5 females; aged 55 to 65 years; history of 5 to 20 years. Case selection criteria 5: 1. The age of 50 years of age or older. 2. Advanced neurological instability symptoms and / or diffuse brain damage symptoms such as headache, dizziness, fatigue, insomnia, drowsiness, memory loss, vague language, finger tremor, walking instability, personality changes, irritability and so on. 3. There is evidence of systemic arteriosclerosis, such as fundus arteriosclerosis Ⅱ level